Funder
U.S. Department of Defense
U.S. Department of Health & Human Services | NIH | National Cancer Institute
Prostate Cancer Foundation
Publisher
Springer Science and Business Media LLC
Reference50 articles.
1. Miyahira, A. K. et al. Meeting report from the Prostate Cancer Foundation PSMA theranostics state of the science meeting. Prostate https://doi.org/10.1002/pros.24056 (2020).
2. Israeli, R. S., Powell, C. T., Corr, J. G., Fair, W. R. & Heston, W. D. Expression of the prostate-specific membrane antigen. Cancer Res. 54, 1807–1811 (1994).
3. Narayan, V. et al. PSMA-targeting TGF-β-insensitive armored CAR T cells in metastatic castration-resistant prostate cancer: a phase 1 trial. Nat. Med. https://doi.org/10.1038/s41591-022-01726-1 (2022).
4. Sartor, O. et al. Lutetium-177–PSMA-617 for metastatic castration-resistant prostate cancer. N. Engl. J. Med. 385, 1091–1103 (2021).
5. Paschalis, A. et al. Prostate-specific membrane antigen heterogeneity and DNA repair defects in prostate cancer. Eur. Urol. 76, 469–478 (2019).
Cited by
40 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献